Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
COVID-19
•
General Rheumatology
•
Inflammatory arthritis
What is your approach to management of inflammatory arthritis in the setting of multisystem inflammatory syndrome in adults (MIS-A) after COVID?
Related Questions
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
How do you approach evaluation and management of a patient with recurrent monoarticular inflammatory arthritis of unclear etiology?
Is there any benefit to checking serum viscosity in patients with autoimmune disease and headaches/migraines to see if aspirin or clopidogrel may be beneficial?
What are some situations where a non-prednisone steroid would be more appropriate than prednisone?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
